Dr Robert Michler

Founder and Chairman of Heart Care International, is an internationally recognized cardiothoracic surgeon, author and lecturer. He is the Surgeon-in-Chief, Samuel I. Belkin Endowed Chair, Professor and Chairman of the Department of Surgery, and Professor and Chairman of the Department of Cardiovascular & Thoracic Surgery at Montefiore Medical Center and Albert Einstein College of Medicine in New York City. He previously served as Professor of Surgery and Chief of Cardiothoracic Surgery and Transplantation at the Ohio State University Medical Center, as well as Director of the Cardiac Transplantation at Columbia-Presbyterian Medical Center in New York City. Dr. Michler received his BA from Harvard University and his MD from Dartmouth Medical School with honors.

He received his medical education at Dartmouth Medical School where he was a Leopold Schepp Scholar. Dr. Michler completed his residency in General Surgery, a fellowship in Cardiothoracic Transplantation and a residency in Cardiothoracic Surgery at the Columbia Presbyterian Medical Center in New York. Robert E. Michler, MD, is Professor and Chairman of the Departments of Surgery and Cardiovascular and Thoracic Surgery, and Director of the Heart Center at the Montefiore Medical Center/Albert Einstein College of Medicine in New York. Robert E. Michler, MD, an internationally renowned cardiothoracic surgeon and researcher, a leader in several specialties, including complex cardiac surgery, heart transplantation, valve repair surgery, ventricular reconstruction for congestive heart failure and minimally invasive cardiac surgery.

Michler reports grant support from the National Institutes of Health/NHLBI during the study. Gardner reports no relevant financial relationships. Disclosures for the other coauthors are listed on www.nejm. Sundt reports personal fees from Thrasos. At 1 year there was no difference between groups in the primary end point of left ventricular end systolic volume index (LVESVI) or the secondary composite end point of major adverse cardiac or cerebrovascular events (death, stroke, subsequent mitral-valve surgery, hospitalization for heart failure, and an increase of one or more NYHA heart failure classes).

Michler is Surgeon-in-Chief at Montefiore Medical Center and Albert Einstein College of Medicine in New York, New York. He is also the Samuel I. Belkin Endowed Chair, Professor and Chairman, Department of Cardiothoracic & Vascular Surgery, Professor and Chairman, Department of Surgery and Co-Director, Montefiore Einstein Center for Heart and Vascular Care. Before joining The Ohio State University faculty in November 1997, Dr. Michler was on the faculty of the Columbia-Presbyterian Medical Center in New York and served as Director of the Cardiac Transplant Program, one of the largest cardiac transplant programs in the nation. Dr. Michler was a tenured Associate Professor of Surgery at Columbia University.

He was awarded the Blakemore Research Prize for three consecutive years. He completed a chief residency in Pediatric Cardiothoracic Surgery with Dr. Aldo Castaneda at the Harvard Medical School, Boston Children’s Hospital. Dr. Michler received his undergraduate education magna cum laude from Harvard University.

Montefiore Medical Center focuses on providing family-centered healthcare in a nurturing environment that extends well beyond hospital and clinic walls. Dr. Michler is a Magna Cum Laude graduate of Harvard University and received his medical degree from Dartmouth Medical School where he was a Leopold Schepp Scholar. He completed his residency in general surgery, fellowships in cardiothoracic surgery and transplantation at Columbia and was chief resident in pediatric cardiothoracic surgery at Harvard Medical School, Boston Children's Hospital. "Dr. Michler's appointment underscores Montefiore's national reputation as a leader in cardiothoracic surgery and our commitment to provide unparalleled, quality care to heart patients in the region," said Dr. Foreman.

Michler is an internationally renowned heart surgeon who specializes in complex heart surgery, aortic and mitral valve repair, coronary artery bypass surgery, aneurysm surgery, and management of the failing heart. In 2017, Dr. Michler received the Vladimir Borakovsky Prize in Moscow from the Ministry of Health of the Russian Federation for “his personal contributions to the development of cardiovascular surgery”. While introducing the presentation, Michler explained that about half of the one million MI patients in the United States develop ischemic mitral regurgitation each year, and moderate regurgitation occurs in more than 10%. Many patients with ischemic mitral regurgitation require surgical revascularization for multivessel CAD, at which time surgeons often consider concomitant mitral-valve repair. But the evidence of whether the additional repair is worthwhile is uncertain, and previous study results have been conflicting.

Michler has particular interest and experience as a turnaround specialist in the healthcare industry. His work experiences at New York Columbia Presbyterian, the Ohio State University Medical Center, and the Montefiore Medical Center/Albert Einstein College of Medicine have led to the creation and implementation of programs in cardiovascular and thoracic surgery, general surgery, organ transplantation, plastic and reconstructive surgery, pediatric surgery, breast surgery and cancer care. Michler was central to the planning, architectural design, and philanthropic development of the Richard M. Ross Heart Hospital. He served as the first executive director of the Richard M. Ross Heart Hospital.

Dr. Michler, a specialist in both adult and pediatric heart surgery, is recognized for advancing the use of minimally invasive techniques for coronary bypass surgery, aortic and mitral valve repair, and novel treatment strategies for heart failure including the use of human muscle cells and bone marrow stem cells. His seminal work in robotics led to FDA approval of robotics for mitral valve repair and for coronary artery bypass surgery. Dr. Michler's vision for the future includes developing new surgical approaches that re-define state-of-the-art care through heart remodeling, surgery for valve repair and treatment of atrial fibrillation, minimally invasive and robotic surgery, heart assist devices and heart transplants, stem cell research and myoblast injections. The study was conducted as part of NHLBI Cardiothoracic Surgical Trials Network and was cofunded by the National Institute for Neurological Diseases and Stroke and Canadian Institutes for Health Research.

He received his medical education at Dartmouth Medical School where he was a Leopold Schepp Scholar. Michler completed his residency in General Surgery, a fellowship in Cardiothoracic Transplantation and a residency in Cardiothoracic Surgery at the Columbia Presbyterian Medical Center in New York.

and Jeanne B. McCoy Endowed Chair, Professor of Surgery, and Chief, Division of Cardiothoracic Surgery and Director, Heart & Lung Transplantation at the Ohio State University Medical Center in Columbus, Ohio. Before joining the Ohio State University, Michler was a tenured Associate Professor of Surgery at Columbia University and served as the Director of the Cardiac Transplantation Program at Columbia-Presbyterian Medical Center in New York.

Each year, Heart Care International sends 150 heart surgeons, nurses, perfusionists, and other specialists—along with 15,000 pounds of equipment—to impoverished countries to perform cardiac surgery on children. Michler has authored over 300 peer-reviewed publications, recently publishing in the New England Journal of Medicine, Circulation and the Journal of Thoracic and Cardiovascular Surgery.

CHICAGO, IL — Patients with moderate ischemic mitral regurgitation undergoing CABG did not show any clinical benefit from adding in mitral-valve repair to the surgery and had a higher rate of neurological adverse effects, according to 1-year results of the largest trial to look at this question to date[1,2]. Montefiore invests more in order to enable compassionate, personalized care and the most positive outcomes for patients and their families in New York, the tri-state area and beyond. Dr. Michler is the principal investigator in current FDA trials to treat congestive heart failure by injecting autologous myoblasts (a patient's own, healthy, leg muscle cells) directly into the diseased heart muscles of patients. This promising research could help treat the 400,000 new cases of heart failure in the US each year. "Our team will help define 'state of the art' care in heart remodeling, surgery for both valve repair and treatment of atrial fibrillation, minimally invasive and robotic surgery, heart assist devices and heart transplants, stem cell research and myoblast injections," said Dr. Michler.

Thoracic and cardiac surgeons have the knowledge, experience and technical skills to accurately diagnose, operate upon safely and effectively manage patients with thoracic diseases of the chest. This requires substantial knowledge of cardiorespiratory physiology and oncology, as well as capability in the use of heart assist devices, management of abnormal heart rhythms and drainage of the chest cavity, respiratory support systems, endoscopy and invasive and noninvasive diagnostic techniques. Montefiore's unique combination of 'state-of-the-art' technology with 'state-of-the-heart' medical and nursing care in a teaching and research environment provides patients with access to world-class medical experts, the newest and most innovative treatments and the best medical center experience anywhere.

Formerly, he held the John G. and Jeanne Bonnet McCoy Endowed Chair, Professor of Surgery, and Chief of Cardiothoracic Surgery and Transplantation at The Ohio State University Medical Center in Columbus, Ohio. He also served as the Associate Director of the Dorothy M. Davis Heart and Lung Research Institute at The Ohio State University. Dr. Michler was integral to the planning, design, and philanthropic development for the Richard M. Ross Heart Hospital. He served as its first Executive Director.

And as the lead investigator in groundbreaking FDA trials, he is pioneering the safe use of injections of autologous human muscle cells and stem cells into diseased heart muscle to treat heart failure. This 1,062 bed medical center includes the Henry and Lucy Moses Division, the Jack D. Weiler Hospital and The Children's Hospital at Montefiore, a large home healthcare agency and a 21-site medical group practice located throughout the Bronx and nearby Westchester. Montefiore treats all major illnesses and has distinguished centers of excellence in cardiology and cardiac surgery, cancer care, tissue and organ transplantation, children's health, women's health, surgery and the surgical subspecialties.

Previously he served as Director of the Cardiac Transplant Program at Columbia-Presbyterian Medical Center in New York City. Formerly, Michler was the John G.

Michler is the chairman and founder of a not-for-profit foundation, Heart Care International, which performs pediatric heart surgery in underserved regions of the world. Since 1994, Heart Care International has helped over 1,500 children with heart disease and performed heart surgery on over 1,000 children. He has received numerous honors including “Person of the Week” by Peter Jennings of ABC World News Tonight, the Pace Humanitarian Award, and “The Order of Christopher Columbus” by Hipólito Mejía, President of the Dominican Republic.

Included is the surgical care of coronary artery disease, cancers of the lung, esophagus and chest wall, abnormalities of the trachea, abnormalities of the great vessels and heart valves, congenital anomalies, tumors of the mediastinum and diseases of the diaphragm. The management of the airway and injuries of the chest is within the scope of the specialty. Dr. Michler currently is the lead investigator in a groundbreaking FDA trial examining whether novel surgery to reshape the human heart will benefit patients with heart failure and coronary artery disease. Spencer Foreman, MD, president of Montefiore and Dominick P. Purpura, MD, dean of AECOM, announced his appointment, effective April 2, 2005. By any measure, Michler does make a difference in the world—a huge difference—in the lives of the 300 to 400 patients a year on whom he operates, in the research projects that he leads, and in a nonprofit called Heart Care International that he founded with his wife, Sally, in 1995.

Dr. Michler joins Montefiore and AECOM from The Ohio State University Medical Center, where he was the John G. and Jeanne B. McCoy Endowed Chair, Professor of Surgery and Chief of Cardiothoracic Surgery and Transplantation from 1997 to 2004.

Dr. Michler began his career on the faculty of Columbia Presbyterian Medical Center/Columbia University in New York City. He rose to become the Director of the Heart Transplantation Program before being recruited to the Ohio State University as the Chief, Division of Cardiothoracic Surgery and Director of the Heart & Lung Transplantation Program. In 2005, Michler returned to New York City as the Chairman of the Department of Cardiothoracic Surgery, and soon thereafter, was appointed Surgeon-in-Chief of the healthcare system and Chairman, Department of Surgery.

In his role as Professor and University Chairman of the Department of Cardiovascular and Thoracic Surgery, Dr. Michler applies his dynamic leadership to expand Montefiore Einstein's role at the forefront of surgical innovation. Thoracic & Cardiac SurgeryCloseA thoracic and cardiac surgeon provides the operative, perioperative care and critical care of patients with pathologic conditions within the chest.

Dr. Michler has authored hundreds of peer-review articles and book chapters in cardiothoracic surgery and heart transplantation. He has received numerous honors and awards, including "Person of the Week" by Peter Jennings of ABC World News Tonight, and "The Order of Christopher Columbus" by Hippolito Mejia, President of the Dominican Republic. Dr. Michler is the Founder and Chairman of Heart Care International, a not-for-profit foundation providing diagnostic heart care and surgery to indigent children in developing countries.

Dr. Michler is a magna cum laude graduate of Harvard University and received his medical degree from Dartmouth Medical School, where he was a Leopold Schepp Scholar. He completed a residency in general surgery and fellowships in cardiothoracic surgery and transplantation at Columbia University and worked as Chief Resident of Pediatric Cardiothoracic Surgery at Harvard Medical School, Boston Children's Hospital. Dr. Michler was tenured Associate Professor of Surgery at Columbia University and Director of Cardiac Transplantation at Columbia Presbyterian Medical Center. Most recently, Dr. Michler was the John G. and Jeanne B. McCoy Chair and Chief of Cardiothoracic Surgery at Ohio State University, where he was instrumental in building the Richard M. Ross Heart Hospital and served as its first executive director.

He is a frequent editor and media authority on heart disease topics.[4][5][6] Over the years, Dr. Michler has provided regular commentary to NBC Nightly News, the New York Times and the Wall Street Journal. Michler lectures extensively, both nationally and abroad, on topics ranging from advances in heart therapies, humanitarian heart surgery programs, “team building” and “leadership” in healthcare, and the design and development of specialty heart hospitals. Harvard University (B.A. Magna Cum Laude)OccupationCardiothoracic Surgeon, author, lecturerRobert E.

NEW YORK, April 1 /PRNewswire/ -- Robert E. Michler, MD, the internationally recognized cardiothoracic surgeon who first used minimally invasive and robotic surgery on heart patients, and who pioneered the safe use of human muscle cell injections to treat congestive heart failure, has been appointed professor and chairman of the Department of Cardiothoracic Surgery at Montefiore Medical Center and Albert Einstein College of Medicine (AECOM) in New York City, NY. Robert E. Michler, MD, an internationally renowned cardiothoracic surgeon and researcher, a leader in several subspecialties, including complex cardiac surgery, heart transplantation, valve repair surgery, ventricular reconstruction for congestive heart failure and minimally invasive cardiac surgery. Of particular note, Dr. Michler was one of the first to perform minimally invasive and robotic surgery in heart patients. His pivotal work in robotics led to Food and Drug Administration (FDA) approval of this advanced technology for mitral valve repair and coronary artery bypass surgery. And as the lead investigator in groundbreaking FDA trials, he is pioneering the safe use of injections of autologous human muscle cells and stem cells into diseased heart muscle to treat heart failure.

Montefiore Medical Center, The University Hospital and Academic Medical Center for the Albert Einstein College of Medicine, ranks among the top one percent of all US hospitals based on its investments in medical innovation and cutting-edge technology. The patient, a man in his mid-fifties, has multi-vessel coronary artery disease (a condition that reduces the flow of blood to the heart muscle), a thickening of the heart wall (a condition called idiopathic hypertrophic subaortic stenosis), and several blockages in the heart itself. After Michler carves away excess muscle tissue from inside the man's heart and aorta, he and the surgical fellow will perform a quadruple bypass. A vein taken from the man's leg will be used to create four alternate routes for blood to bypass the clogged portions of the coronary arteries and flow into the heart tissue. It's a complex case but a typical one for Michler, who is chair of cardiothoracic surgery at Montefiore Medical Center in the Bronx.

Of particular note, Dr. Michler was one of the first to perform minimally invasive and robotic surgery in heart patients. His pivotal work in robotics led to Food and Drug Administration (FDA) approval of this advanced technology for mitral valve repair and coronary artery bypass surgery.

Dr. Michler’s vision for the future includes developing new surgical approaches that re-define state-of-the-art care through heart remodeling, surgery for valve repair and treatment of atrial fibrillation, minimally invasive and robotic surgery, heart assist devices and heart transplants, stem cell research and myoblast injections. DMS graduate Robert Michler, chair of cardiothoracic surgery at New York's Montefiore Medical Center, is all business in the OR but all heart underneath. Michler received his undergraduate education Magna Cum Laude from Harvard University.

He received his medical education at Dartmouth Medical School where he was a Leopold Schepp Scholar. Dr. Michler completed his residency in General Surgery, a fellowship in Cardiothoracic Transplantation and a residency in Cardiothoracic Surgery at the Columbia Presbyterian Medical Center in New York. Robert E. Michler, MD, is Professor and Chairman of the Departments of Surgery and Cardiovascular and Thoracic Surgery, and Director of the Heart Center at the Montefiore Medical Center/Albert Einstein College of Medicine in New York. Robert E. Michler, MD, an internationally renowned cardiothoracic surgeon and researcher, a leader in several specialties, including complex cardiac surgery, heart transplantation, valve repair surgery, ventricular reconstruction for congestive heart failure and minimally invasive cardiac surgery.

Founder and Chairman of Heart Care International, is an internationally recognized cardiothoracic surgeon, author and lecturer. He is the Surgeon-in-Chief, Samuel I. Belkin Endowed Chair, Professor and Chairman of the Department of Surgery, and Professor and Chairman of the Department of Cardiovascular & Thoracic Surgery at Montefiore Medical Center and Albert Einstein College of Medicine in New York City. He previously served as Professor of Surgery and Chief of Cardiothoracic Surgery and Transplantation at the Ohio State University Medical Center, as well as Director of the Cardiac Transplantation at Columbia-Presbyterian Medical Center in New York City. Dr. Michler received his BA from Harvard University and his MD from Dartmouth Medical School with honors.

Michler has particular interest and experience as a turnaround specialist in the healthcare industry. His work experiences at New York Columbia Presbyterian, the Ohio State University Medical Center, and the Montefiore Medical Center/Albert Einstein College of Medicine have led to the creation and implementation of programs in cardiovascular and thoracic surgery, general surgery, organ transplantation, plastic and reconstructive surgery, pediatric surgery, breast surgery and cancer care. Michler was central to the planning, architectural design, and philanthropic development of the Richard M. Ross Heart Hospital. He served as the first executive director of the Richard M. Ross Heart Hospital.

Michler is an internationally renowned heart surgeon who specializes in complex heart surgery, aortic and mitral valve repair, coronary artery bypass surgery, aneurysm surgery, and management of the failing heart. In 2017, Dr. Michler received the Vladimir Borakovsky Prize in Moscow from the Ministry of Health of the Russian Federation for “his personal contributions to the development of cardiovascular surgery”. While introducing the presentation, Michler explained that about half of the one million MI patients in the United States develop ischemic mitral regurgitation each year, and moderate regurgitation occurs in more than 10%. Many patients with ischemic mitral regurgitation require surgical revascularization for multivessel CAD, at which time surgeons often consider concomitant mitral-valve repair. But the evidence of whether the additional repair is worthwhile is uncertain, and previous study results have been conflicting.

Michler reports grant support from the National Institutes of Health/NHLBI during the study. Gardner reports no relevant financial relationships. Disclosures for the other coauthors are listed on www.nejm. Sundt reports personal fees from Thrasos. At 1 year there was no difference between groups in the primary end point of left ventricular end systolic volume index (LVESVI) or the secondary composite end point of major adverse cardiac or cerebrovascular events (death, stroke, subsequent mitral-valve surgery, hospitalization for heart failure, and an increase of one or more NYHA heart failure classes).

Michler is Surgeon-in-Chief at Montefiore Medical Center and Albert Einstein College of Medicine in New York, New York. He is also the Samuel I. Belkin Endowed Chair, Professor and Chairman, Department of Cardiothoracic & Vascular Surgery, Professor and Chairman, Department of Surgery and Co-Director, Montefiore Einstein Center for Heart and Vascular Care. Before joining The Ohio State University faculty in November 1997, Dr. Michler was on the faculty of the Columbia-Presbyterian Medical Center in New York and served as Director of the Cardiac Transplant Program, one of the largest cardiac transplant programs in the nation. Dr. Michler was a tenured Associate Professor of Surgery at Columbia University.